Pharmaron Beijing Co., Ltd. (HKG:3759)
13.72
+0.52 (3.94%)
Apr 24, 2025, 4:08 PM HKT
Pharmaron Beijing Revenue
In the year 2024, Pharmaron Beijing had annual revenue of 12.28B CNY with 6.39% growth. Pharmaron Beijing had revenue of 3.46B in the quarter ending December 31, 2024, with 16.15% growth.
Revenue
12.28B CNY
Revenue Growth
+6.39%
P/S Ratio
3.09
Revenue / Employee
574.44K CNY
Employees
21,370
Market Cap
40.33B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 12.28B | 737.78M | 6.39% |
Dec 31, 2023 | 11.54B | 1.27B | 12.39% |
Jan 1, 2023 | 10.27B | 2.82B | 37.92% |
Dec 31, 2021 | 7.44B | 2.31B | 45.00% |
Dec 31, 2020 | 5.13B | 1.38B | 36.64% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
WuXi Biologics | 19.87B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
Alibaba Health Information Technology | 31.39B |
CSPC Pharmaceutical Group | 30.87B |